Chargement en cours...

Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations

BACKGROUND: Options for opioid agonist therapy (OAT) are expanding with the development of prolonged-release (also known as extended-release) 1-week, 1-month, and 6-month formulations of buprenorphine. There is an assumption that patients will welcome these new treatments and medication adherence wi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Harm Reduct J
Auteurs principaux: Neale, Joanne, Tompkins, Charlotte N. E., Strang, John
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6446264/
https://ncbi.nlm.nih.gov/pubmed/30943990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12954-019-0296-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!